Archived Webcast of FDA News FDA Information Management Summit -
CONTACT:
[email protected]
703-961-9250

FDA has a whole slew of new rules on how it wants to communicate with industry. Need a crash course? Get ready for FDA's new and evolving electronic requirements with this two-day, must-attend conference. You'll walk away with a winning formula for eliminating communication bottlenecks with the FDA.

Hear straight from top FDA insiders — Beth Duvall-Miller (CDER), Steven Gitterman (CDER), Robert Gatling (CDRH), Joseph Montgomery (CBER) and Toni Stefano (CBER) — all key officials in FDA's electronic initiatives. New FDA Gateway Program, Elabeling, Esubmissions, Computer Validation and More!

Discover how to use FDA's Gateway Program — a portal through which the industry will communicate with all FDA centers — to communicate successfully with the FDA. Learn from 17 leading industry pros, including five top FDA officials, how to use the latest electronic tools to speed review of your submissions and get your product to market faster. Register today for pre-conference workshops and 12 interactive conference sessions covering —

  • Clinical Data Interchange Standards (CDISC)
  • Elabeling
  • NDA, ANDA, IND and BLA submissions
  • Electronic records and signatures
    Secure email
  • Adverse event reporting
  • Post-marketing commitments
  • Inspections and audit trails
  • Risk-based computer validation
  • CTD preparation
    Minimum system requirements for viewing webcast: P3 500Mhz with 8MB video memory with Windows Media Player or Real Player (newestversions preferred)

Implementing the New Clinical Data Interchange Standards (CDISC)

Windows
Media high
Windows
Media low

----------------------------------

Update on FDA Center E-submissions, Part I

Windows
Media high
Windows
Media low

----------------------------------

Update on FDA Center E-submissions, Part II

Windows
Media high
Windows
Media low

----------------------------------

Using IT to Speed Up the Submission Process

Windows
Media high
Windows
Media low

----------------------------------

Electronic Signatures: From Fist Signing to E-Submissions

Windows
Media high
Windows
Media low

----------------------------------

Applying the Risk-Based Concept to Clinical Trial Data

Windows
Media high
Windows
Media low

----------------------------------

Keynote Luncheon Address: Impact of FDA's Latest Guidance on Part 11

Windows
Media high
Windows
Media low

----------------------------------

Communicating Results of Post-Marketing Commitment Studies

Windows
Media high
Windows
Media low

----------------------------------

Responding to Inspection Observations

Windows
Media high
Windows
Media low

----------------------------------

Pre-Conference Workshop

Windows
Media high
Windows
Media low
Maintaining Computer SYstems in a Validated State: A Risk-Based Approach

----------------------------------

1_teaser

Windows
Media high
Windows
Media low

----------------------------------

2_teaser

Windows
Media high
Windows
Media low

----------------------------------

3_teaser

Windows
Media high
Windows
Media low

----------------------------------

4_teaser

Windows
Media high
Windows
Media low

----------------------------------

5_teaser

Windows
Media high
Windows
Media low

----------------------------------

6_teaser

Windows
Media high
Windows
Media low

----------------------------------

7_teaser

Windows
Media high
Windows
Media low

----------------------------------

8_teaser

Windows
Media high
Windows
Media low

----------------------------------

9_teaser

Windows
Media high
Windows
Media low

----------------------------------

10_teaser

Windows
Media high
Windows
Media low

----------------------------------